Please Wait.....
Report
Philippines Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
Market Report I 2024-02-17 I 70 Pages I Mordor Intelligence
Philippines diabetes drugs and devices market size is estimated at USD 0.3 billion in the current year. The market is expected to reach USD 0.4 billion in five years, registering a CAGR of more than 4% during the forecast period.
COVID-19 is a new disease caused by the SARS-CoV-2 virus strain. Most people infected with the virus develop mild to moderate respiratory illness and recover without specific treatment. Older people and people with underlying medical conditions such as diabetes, high blood pressure, heart disease, lung disease, obesity, and cancer are at increased risk of developing serious illnesses. The virus invades multiple cells in the body, including the heart and lungs, causing inflammatory changes that lead to inflammation and damage to multiple organs. Diabetes and systemic inflammation are linked. Studies have shown that people with diabetes have higher viral entry, lower immune responses, lower viral clearance, and dysregulation of inflammatory markers.
People with diabetes may be at the same risk of contracting COVID-19 as nondiabetics. On the other hand, people with diabetes are at increased risk of hospitalization, ICU admission, severe outcomes and death after being infected with COVID-19 due to the essential features of the disease.
Diabetes is a complex disease characterized by elevated blood sugar levels resulting from impaired insulin production and\/or action. Insulin is a pancreatic hormone that controls blood sugar levels in the body. Uncontrolled diabetes has many effects, including heart attacks, strokes, amputations, blindness, and kidney failure. According to DOST-FNRI data, prediabetes affects approximately 14.2% of the population. Combining diabetes and prediabetes, one in five Filipinos has abnormal blood sugar levels.
Thus, the above factors are expected to drive market growth over the forecast period.
Philippines Diabetes Drugs and Devices Market Trends
The continuous Glucose Monitoring Segment is Expected to Witness the Highest Growth Rate Over the Forecast Period
Continuous blood glucose monitors help people with type 1 and type 2 diabetes manage their diabetes with fewer finger tests. This wearable tech device tracks blood sugar levels via an app. Most CGM machines take readings every 5-10 minutes throughout the day. A CGM device uses a wireless transmitter to transmit glucose data from the sensor to the receiver.
Diabetes has a disproportionate economic impact on patients in low- and middle-income countries. The emergence of complications can also increase medical costs, which significantly impacts the direct medical costs of diabetes. HTAC aims to add insulin analogues to Philippine prescriptions to reduce costs and influence government debate. As this practice becomes more widespread, improving primary care units and referral networks is essential to build a robust infrastructure for delivering diabetes care. Diabetes treatment in the Philippines is limited in resources, government support and economics. In a preventive approach, the National Health System does not fully cover diabetes treatment and private insurance companies offer only minimal diabetes coverage. For this reason, most patients rely on out-of-pocket expenses such as laboratory tests and daily prescriptions.
Awareness programs for continuous blood glucose monitoring devices are being implemented around the Philippines. Technological advancements in CGM devices are driving the market during the forecast period.
Rising diabetes prevalence
Diabetes is a complex disease characterized by elevated blood sugar levels caused by impaired insulin synthesis and action. Insulin is a pancreatic hormone that regulates blood sugar levels. Left untreated, diabetes can lead to heart attack, stroke, amputation, blindness, and kidney failure. According to DOST-FNRI statistics, prediabetes affects approximately 14.2% of the population. One in five Filipinos has abnormal blood sugar levels when diabetes and pre-diabetes are combined. Significant barriers to healthcare exist in the Philippines, including high out-of-pocket costs due to limited healthcare funding and a fragmented referral system from general practice to speciality clinics. Increase. Budgetary constraints from the economic slowdown and severe supply shortages have made access to diabetes care equipment even more difficult in the Philippines during the COVID-19 outbreak. Identifying and removing these barriers is critical to solving the problem of access to insulin and diabetes care within the country. Millions of people in low- and middle-income countries (LMICs) do not have access to insulin or regular diabetes treatment. The Philippines, a lower-middle-income Southeast Asian country with more than 4 million adults with diabetes, is not immune to this problem.
The increasing diabetes prevalence and the above factors will likely drive segment growth over the forecast period.
Philippines Diabetes Drugs and Devices Industry Overview
Manufacturers have constantly innovated to survive in the market.Novo Nordisk partnered with Abbott Diabetes Care, which may also assist to enable insulin statistics to be shared between Novo Nordisk-connected insulin pens and digital fitness equipment well suited to the FreeStyle Libre portfolio of products.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products and Services
4.3.5 Intensity of Competitive Rivalry
5 Market Segmentation (Market Size by Value - USD)
5.1 Devices
5.1.1 Monitoring Devices
5.1.1.1 Self-monitoring Blood Glucose Devices
5.1.1.2 Continuous Blood Glucose Monitoring
5.1.2 Management Devices
5.1.2.1 Insulin Pump
5.1.2.2 Insulin Syringes
5.1.2.3 Insulin Cartridges
5.1.2.4 Disposable Pens
5.2 Drugs
5.2.1 Oral Anti-Diabetes Drugs
5.2.2 Insulin Drugs
5.2.3 Combination Drugs
5.2.4 Non-Insulin Injectable Drugs
6 Market Indicators
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population
7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Novo Nordisk
7.1.2 Medtronic
7.1.3 Insulet
7.1.4 Tandem
7.1.5 Ypsomed
7.1.6 Novartis
7.1.7 Sanofi
7.1.8 Eli Lilly
7.1.9 Abbottt
7.1.10 Roche
7.1.11 Astrazeneca
7.1.12 Dexcom
7.1.13 Pfizer
7.2 Company Share Analysis
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security